SCHEMBL28340951

SCHEMBL28340951

O=C(O)N1C[C@H]2CCC[C@H]2C1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 0.52
CHRNB2 P17787 7/20 0.35
CHRNA3 P32297 7/20 0.35
CHRNA4 P43681 7/20 0.35
CHRNB4 P30926 5/20 0.35
CHRNA7 P36544 3/20 0.35
CHRNB3 Q05901 2/20 0.34
CHRNA6 Q15825 2/20 0.34
HSD11B2 P80365 1/20 0.34
L3MBTL3 Q96JM7 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
VNN1 O95497 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830410 1.00 HSD11B1 (0.52) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
Bromide SCHEMBL17009295 0.97 HSD11B1 (0.50) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL6015474 0.95 HSD11B1 (0.58) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL4022475 0.92 HSD11B1 (0.61) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
Hydrochloric Acid SCHEMBL6016934 0.92 HSD11B1 (0.56) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL30832718 0.89 HSD11B1 (0.44) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL20958523 0.88 HSD11B1 (0.42) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL20958521 0.88 HSD11B1 (0.42) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL30589050 0.86 HSD11B1 (0.50) HSD11B1L3MBTL3
SCHEMBL18498063 0.83 CHRNB2 (0.39) HSD11B1CHRNB2CHRNA3CHRNA4CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110603252-A Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders 艾其林医药公司 2019-12-20 CN disclosed